First Turn Management, LLC

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1993440 DEL MAR, CA

Position in FULC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$17,304,356

-$4,101,888 QoQ

Shares Held

2,256,109

+19.2% QoQ

Ownership

3.39%

of shares outstanding

% of Portfolio

1.93%

of 13F equity value

Holder Rank

of 168 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

First Turn Management, LLC holds $816,783,749 across 31 Biotechnology names. FULC ranks #24 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	465,869	$51,874,513
2	BBIO	BridgeBio Pharma, Inc.	695,718	$51,664,018
3	XENE	Xenon Pharmaceuticals Inc.	786,844	$45,754,978
4	RVMD	Revolution Medicines, Inc.	468,376	$45,549,566
5	APGE	Apogee Therapeutics, Inc.	513,770	$43,244,020
6	INSM	INSMED Inc	248,475	$40,630,632
7	NUVL	Nuvalent, Inc.	370,344	$37,941,742
8	MIRM	Mirum Pharmaceuticals, Inc.	400,464	$36,994,864

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$17,304,356	2,256,109	+19.2%	Shares	Sole	2026-05-15
2025-12-31	$21,406,244	1,892,683	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.